Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Manidipine (Iperten) 是一种二氢吡啶类钙通道阻滞剂,有降压作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 223 | 现货 | ||
5 mg | ¥ 512 | 现货 | ||
10 mg | ¥ 748 | 现货 | ||
25 mg | ¥ 1,250 | 现货 | ||
50 mg | ¥ 1,850 | 现货 | ||
100 mg | ¥ 2,760 | 现货 | ||
200 mg | ¥ 3,950 | 现货 | ||
500 mg | ¥ 6,330 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 688 | 现货 |
产品描述 | Manidipine (Iperten), a calcium channel blocker, which is dihydropyridine type. It is utilized |
靶点活性 | Ca2+ channel:2.6 nM |
体外活性 | Manidipine, a Ca(2+)-channel blocker, at concentrations that lower elevated blood pressure, modulates the transcription rates of cytokine genes in the mesangial cells of humans that had been stimulated with platelet-derived growth factor BB isomer. [1] Manidipine inhibits the ET-1-induced [Ca2+]i increase by reducing both the transient and sustained Ca2+ increments in A7r5 cells and glomerular mesangial cells (MCs). Manidipine (10(-5) mol/L) potentiates ET-1-induced c-fos and c-jun expression in A7r5 cells. Manidipine is a potent inhibitor for ET-1-induced [Ca2+]i signaling and that Manidipine has multiple effects on ET-1-induced signaling, including potentiating the immediate-early gene response. [2] |
体内活性 | Manidipine reduces systolic blood pressure with a slight sympathetic reflex increase in heart rate, and increases plasma nitrite/nitrates in perfused rat heart from ischemia-reperfusion damage. Manidipine combined with Simvastatin reduces creatine kinase, lactate dehydrogenase and tumor necrosis factor-alpha, and enhancement of 6-keto-PGF(1alpha) during reperfusion. [3] Manidipine hydrochloride prevents isoproterenol-induced left ventricular hypertrophy and expression of mRNA of ANP, collagen types I and type III, and fibronectin in rats with isoproterenol-induced cardiac hypertrophy. [4] Manidipine HCl increases renal blood flow (RBF) by dilating the afferent arterioles and improves glomerular hypertension by dilating the efferent arterioles in hypertensive rats. [5] |
别名 | Iperten, Franidipine, Artedil, 马尼地平 |
分子量 | 610.7 |
分子式 | C35H38N4O6 |
CAS No. | 89226-50-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 113 mg/mL (185 mM)
Ethanol: 3 mg/mL (4.91 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 1.6375 mL | 8.1873 mL | 16.3747 mL | 40.9366 mL |
DMSO | 5 mM | 0.3275 mL | 1.6375 mL | 3.2749 mL | 8.1873 mL |
10 mM | 0.1637 mL | 0.8187 mL | 1.6375 mL | 4.0937 mL | |
20 mM | 0.0819 mL | 0.4094 mL | 0.8187 mL | 2.0468 mL | |
50 mM | 0.0327 mL | 0.1637 mL | 0.3275 mL | 0.8187 mL | |
100 mM | 0.0164 mL | 0.0819 mL | 0.1637 mL | 0.4094 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Manidipine 89226-50-6 Membrane transporter/Ion channel Metabolism Calcium Channel Inhibitor inhibit Ca channels Iperten Ca2+ channels Franidipine Artedil 马尼地平 inhibitor